Series A Preferred Stock [Member] Equity Components [Axis] Series B Preferred Stock [Member] Share Purchase Warrants[Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Hierarchy [Axis] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Carrying Value [Member] Fair Value [Member] Officer Director [Member] Title of Individual [Axis] Common Stock [Member] Additional Paid-In Capital Retained Earnings / Accumulated Deficit Accumulated other Comprehensive Income / Loss Common Stock Accumulated Deficit Unvested Options [Member] Stock Options [Member] Weighted Average Inputs [Member] Weighted Average Inputs One[Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement [Table] Statement [Line Items] ASSETS Current Assets Cash Prepaid expenses and deposits Total Current Assets LIABILITIES AND STOCKHOLDERS’ DEFICIT Current Liabilities Accounts payable and accrued liabilities Research agreement obligations Derivative liability – warrants Promissory notes Total Current Liabilities Stockholders’ Deficit Convertible preferred stock, $0.001 par value — 10,000,000 shares authorized: Common stock, $0.001 par value, 500,000,000 shares authorized 62,890,763 shares issued and outstanding (2014 – 20,318,815) Additional paid-in capital Accumulated deficit Total Stockholders’ Deficit Total LIABILITIES AND STOCKHOLDERS’ DEFICIT Common stock par value Common stock shares authorized Common stock shares issued Common stock shares outstanding Convertible preferred stock Preferred stock par value Preferred stock shares designated Preferred stock issued Preferred stock outstanding Income Statement [Abstract] Operating expenses: General and administrative Research and development Total Operating expense Loss from Operations Other Income (Expense) Foreign exchange gain Accretion of interest on convertible debt Changes in fair value of derivative liabilities Interest and finance charges Shares issued in settlement agreement Loss on settlement of debt Inducement expense Net Income (Loss) for the Period Other comprehensive income (loss) Foreign exchange translation adjustment TOTAL COMPREHENSIVE Income (LOSS) Basic Net Income (Loss) per Share Diluted Net Income (Loss) per Share WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING DILUTED Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net loss Adjustments to reconcile net loss to net cash from operating activities: Changes in fair value of derivative liabilities Inducement expense Loss on settlement of debt Loss on settlement agreement Accretion of interest on convertible debt Share-based compensation Changes in operating assets and liabilities: Prepaid expenses and deposits Accounts payable and accrued liabilities NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES Private placement, net of finders’ fee Proceeds from loans payable Proceeds from exercise of warrants Repayment of promissory notes NET CASH PROVIDED BY FINANCING ACTIVITIES INCREASE IN CASH CASH, BEGINNING OF YEAR CASH, END OF YEAR SUPPLEMENTAL SCHEDULE OF NON-CASH ACTIVITIES Accounts payable settled in common stock Conversion of debt obligations into common stock: Accrued interest Convertible notes payable Loans payable, related party Promissory notes, related party Due to related parties Fair value derivative liability – conversion option at conversion Balance, Share Balance, Amount Accounts payable settled in shares Accounts payable settled in Amount Private placement (net of finders’ fee of $454,000) Share Private placement (net of finders’ fee of $454,000) Amount Fair value of warrants recognized as derivative liabilities, Share Exercise of warrants, Share Exercise of warrants, Amount Inducement expense on incremental value associated with modified warrants Inducement expense on incremental value associated with modified warrants Shares issued in settlement agreement, Shares Shares issued in settlement agreement, Amount Stock- based compensation, Share Stock- based compensation, Amount Net loss Balance, Share Balance, Amount Statement of Stockholders' Equity [Abstract] Net of finders' fee Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF OPERATIONS BASIS OF PRESENTATION Notes to Financial Statements LIQUIDITY AND FINANCIAL CONDITION Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NET INCOME (LOSS) PER SHARE DERIVATIVE LIABILITY - WARRANTS AND DERIVATIVE LIABILITY – CONVERSION OPTION PROMISSORY NOTE CAPITAL STOCK Subsequent Events SUBSEQUENT EVENTS Prior Period Reclassifications Computation of income (loss) per share Net loss per share Valuation methodology Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis Measured at fair value Numerous extinguishment agreements Weighted average assumptions: Share Purchase Warrants Share purchase options Liquidity And Financial Condition Details Narrtive Cash and cash equivalents Net income (loss) Weighted average shares outstanding - basic Common stock warrants Common stock options Weighted average shares outstanding - diluted Net loss per share data: Basic Diluted Common stock options Common stock warrants - equity treatment Common stock warrants - liability treatment Convertible notes Potentially dilutive securities Range [Axis] Contractual Life (Years) Risk free Rate Dividend yield Volatility Strike price Fair market value of stock Derivative liability - warrants Total Balance - December 31, 2014 Additions during the quarter Change in fair value of warrant liability Balance – September 30, 2015 Dividend yield (per share) Volatility (annual) Risk-free rate Contractual term (years) Fair value of Conversion Option at extinguishment Outstanding promissory notes Promissory notes officer and a director Strike price minimum Strike price maximum Risk-free rate maximum Risk-free rate minimum Volatility (annual) maximum Volatility (annual) minimum Contractual term (years) minmum Contractual term (years) maximum Equity [Abstract] Number of Warrants Balance, December 31, 2014 Issued Exercised Extinguished or expired Balance, September 30, 2015 Weighted Average Exercise Price Balance, December 31, 2014 Issued Exercised Extinguished or expired Balance, September 30, 2015 Weighted Average Remaining Life Balance, December 31, 2014 Issued Exercised Extinguished or expired Balance, September 30, 2015 Outstanding at January 1, 2014 Cancelled/Forfeited Balance, December 31, 2014 Issued Balance, September 30, 2015 Exercisable at September 30, 2015 Outstanding at January 1, 2014 Cancelled/Forfeited Balance, December 31, 2014 Issued Balance, September 30, 2015 Exercisable at September 30, 2015 Balance, December 31, 2013 Balance, December 31, 2014 Issued Balance, September 30, 2015 Exercisable at September 30, 2015 Outstanding at January 1, 2014 Issued Cancelled/Forfeited Balance, December 31, 2014 Exercisable at September 30, 2015 Number of Shares Unvested, December 31, 2014 Granted Vested Cancelled Unvested, June 30, 2015 Weighted Average Grant-Date Fair Value Unvested, December 31, 2014 Granted Vested Cancelled Unvested, June 30, 2015 Warrant exercised Warrant Shares exercised Intrinsic value of the vested options Common stock warrants - equity treatment. Common stock warrants - liability treatment. Convertible notes. Assets, Current Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Other Extraordinary Gain (Loss) ForeignExchangeGain Interest and Debt Expense Other Comprehensive Income (Loss), before Tax Increase (Decrease) in Derivative Liabilities Extinguishment of Debt, Gain (Loss), Income Tax Interest Income, Securities, Corporate Debt, Operating Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Partners' Capital Account, Private Placement of Units Net Cash Provided by (Used in) Financing Activities Cash, Period Increase (Decrease) Shares, Issued InducementExpenseOnIncrementalValueAssociatedWithModifiedWarrantsAmount Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Option Indexed to Issuer's Equity, Shares Derivative Liability, Fair Value, Gross Liability Derivative, Fair Value, Net Financial and Nonfinancial Liabilities, Fair Value Disclosure Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term Exercised [Default Label] ExtinguishedOrExpired Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber1 Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractual Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Intrinsic Value, Amount Per Share ExercisableIntrinsieValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value